Evidence map›Paper›PMID 7758885›Full record

ArticleDiabetologia1995

Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

C M Forsblom, J G Eriksson, A V Ekstrand, A M Teppo, M R Taskinen, L C Groop

Open access · bronzeAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Diabetologia, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 89 citations in OpenAlex.

  1. Utilization of Mind-Body Intervention for Integrative Health Care of COVID-19 Patients and Survivors.International journal of environmental research and public health · 2022
    Review
  2. Lipid mediators of insulin signaling in diabetic kidney disease.American journal of physiology. Renal physiology · 2019
    Review
  3. Review
  4. Article
  5. Insulin signaling: implications for podocyte biology in diabetic kidney disease.Current opinion in nephrology and hypertension · 2015
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2012
    Article
  12. Podocytopathy in diabetes: a metabolic and endocrine disorder.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2011
    Review
  13. Predictors of incident albuminuria in the Framingham Offspring cohort.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2010
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

C M ForsblomFourth Department of Medicine, Helsinki University Hospital, Finland.
J G Eriksson
A V Ekstrand
A M Teppo
M R Taskinen
L C Groop
Helsinki University Hospital · FIUniversity of Helsinki · FILund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microalbuminuria has recently been associated with insulin resistance in both insulin-dependent and non-insulin-dependent (NIDDM) diabetes mellitus. To establish whether microalbuminuria in non-diabetic subjects as well is associated with insulin resistance and associated abnormalities in glucose and lipid metabolism, oral glucose tolerance tests were performed with measurement of urinary albumin excretion rate, lipids and lipoproteins in 582 male non-diabetic first-degree relatives of patients with NIDDM. In addition, insulin sensitivity was assessed in 20 of these subjects with the euglycaemic hyperinsulinaemic clamp technique. Abnormal albumin excretion rate (AER), defined as AER 15-200 micrograms/min, was associated with higher systolic blood pressure (p < 0.05), higher fasting glucose values (p < 0.05), lower HDL-cholesterol (p < 0.05) and lower apolipoprotein A-I (p < 0.05) concentrations than observed in subjects with normal AER. The rate of glucose metabolism was lower in subjects with abnormal compared to subjects with normal albumin excretion rate (38.0 +/- 2.8 vs 47.3 +/- 2.4 mumol.kg lean body mass-1.min-1; p = 0.028). This difference was almost completely accounted for by a reduction in non-oxidative glucose metabolism (17.7 +/- 1.9 vs 27.4 +/- 2.7 mumol.kg lean body mass-1.min-1; p = 0.010), which correlated inversely with the AER (r = -0.543; p = 0.013). These results suggest that in non-diabetic individuals genetically predisposed to NIDDM, abnormal AER is associated with insulin resistance and abnormalities in glucose and lipid metabolism.

Indexed as

Blood PressureAlbuminuriaApolipoproteinsBlood GlucoseCholesterolCreatinineDiabetes Mellitus, Type 2FamilyGlucose Clamp TechniqueHumansInfusions, IntravenousInsulinInsulin ResistanceLipidsLipoproteinsMaleApolipoproteinsBlood GlucoseCholesterolCreatinineInsulinLipidsLipoproteinsTriglycerides

Identifiers

PMID7758885
OpenAlexW2006242568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.